MDCX Medicus Pharma Ltd. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
19:12
Feb 10
Raza Bokhari Executive Chairman and CEO, Medicus Pharma Bloomberg Markets
Medicus AI trials with insider backing
Medicus Pharma is using generative AI with Reliant AI to run more efficient Phase 2 trials through dynamic site selection, patient stratification, and recruitment prediction. Insiders have $18 million invested at $4, and he expects Phase 2 catalysts and execution in the first half to be rewarded by investors, as prior basal-cell carcinoma data was.
MDCX 1ST
HIGH

About MDCX Investor Commentary

Across the available history and selected sources, Buzzberg tracks MDCX (Medicus Pharma Ltd.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Raza Bokhari.